O'Leary James J 4
4 · Fusion Pharmaceuticals Inc. · Filed Feb 3, 2022
Insider Transaction Report
Form 4
O'Leary James J
Chief Medical Officer
Transactions
- Award
Common Stock
2021-08-31+1,722→ 2,022 total - Award
Stock Option (Right to Buy)
2022-02-01+159,000→ 159,000 totalExercise: $7.70Exp: 2032-02-01→ Common Stock (159,000 underlying)
Footnotes (2)
- [F1]These shares were purchased pursuant to the issuer's 2020 Employee Stock Purchase Plan.
- [F2]This option vests in 48 equal monthly installments beginning on March 1, 2022.